Login

Matt Brown, CFO of Livetiles Ltd (ASX: LVT), discussed with Satori Fund's Founder Dan Niles about energy prices being a significant concern. 00:10:00

Share On Facebook Share On Twitter

LiveTiles is managed by CEO David Vander.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Pablo Martín Presents Izertis to Investors at Madrid Stock Exchange Bell Ringing | Pablo Martin, CEO, IZERTIS SA.
00:10:00
Harnessing Hydrogen's Role in the Green Economy
00:10:00
Centrica CEO Chris O'Shea presents the company's 2022 preliminary financial results.
00:10:00
Randy Kurtz’s Data Driven Advisor Program: Transforming Financial Planning | Randy Kurtz, President , Upper Left Wealth Management.
00:10:00
Charles Murray on America's Civic Culture and Family Changes|Charles Murray
00:10:00
Expert, Fee-Only Financial Guidance for All Life Stages
00:10:00
Signal Gold: Developing Nova Scotia's Highest Grade Gold Deposit
00:10:00
Driving Growth and Transformation: A Deep Dive into Manulife's Strategy and Success| Roy Gori, CEO , Manulife Investment Management.
00:10:00
invests in remarkable entrepreneurs working at the intersection|Bill Evans,General Partner,Rock Health Capital
00:10:00
Neil Ferguson on Academic Betrayal and Cancel Culture: Uncommon Knowledge|Niall Ferguson
00:10:00
The Venture Reality Fund or The VR Fund, is the leading early-stage venture investor is Seed and Series A stage companies|Tipatat Chennavasin,Co-Founder and General Partner,The Venture Reality Fund/VRF
00:00:00
John Bonfiglio, Ph.D., Chairman and CEO of TapImmune, Inc.

© 2026 Nehu